Coherus BioSciences (CHRS) Revenue & Revenue Breakdown
Coherus BioSciences Revenue Highlights
Latest Revenue (Y)
$257.24M
Latest Revenue (Q)
$64.98M
Main Segment (Y)
Product Revenue
Main Geography (Y)
UNITED STATES
Coherus BioSciences Revenue by Period
Coherus BioSciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $257.24M | 21.89% |
| 2022-12-31 | $211.04M | -35.37% |
| 2021-12-31 | $326.55M | -31.37% |
| 2020-12-31 | $475.82M | 33.63% |
| 2019-12-31 | $356.07M | 22783.74% |
| 2018-12-31 | $1.56M | - |
| 2017-12-31 | $1.56M | -99.18% |
| 2016-12-31 | $190.11M | 532.82% |
| 2015-12-31 | $30.04M | -3.42% |
| 2014-12-31 | $31.11M | 1030.72% |
| 2013-12-31 | $2.75M | 44.87% |
| 2012-12-31 | $1.90M | - |
Coherus BioSciences generated $257.24M in revenue during NA 2023, up 21.89% compared to the previous quarter, and up 16532.39% compared to the same period a year ago.
Coherus BioSciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $64.98M | -15.68% |
| 2024-03-31 | $77.06M | -15.80% |
| 2023-12-31 | $91.52M | 22.74% |
| 2023-09-30 | $74.57M | 27.00% |
| 2023-06-30 | $58.72M | 81.02% |
| 2023-03-31 | $32.44M | -28.48% |
| 2022-12-31 | $45.35M | -0.16% |
| 2022-09-30 | $45.42M | -24.48% |
| 2022-06-30 | $60.15M | 0.06% |
| 2022-03-31 | $60.12M | -18.07% |
| 2021-12-31 | $73.37M | -11.07% |
| 2021-09-30 | $82.50M | -5.86% |
| 2021-06-30 | $87.64M | 5.55% |
| 2021-03-31 | $83.03M | -24.80% |
| 2020-12-31 | $110.42M | -2.76% |
| 2020-09-30 | $113.55M | -16.31% |
| 2020-06-30 | $135.67M | 16.78% |
| 2020-03-31 | $116.18M | -6.20% |
| 2019-12-31 | $123.86M | 10.90% |
| 2019-09-30 | $111.68M | 33.86% |
| 2019-06-30 | $83.43M | 124.90% |
| 2019-03-31 | $37.10M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | -100.00% |
| 2017-06-30 | $1.40M | 766.46% |
| 2017-03-31 | $161.00K | -80.92% |
| 2016-12-31 | $844.00K | -99.48% |
| 2016-09-30 | $162.84M | 1057.49% |
| 2016-06-30 | $14.07M | 13.83% |
| 2016-03-31 | $12.36M | 21.19% |
| 2015-12-31 | $10.20M | 42.29% |
| 2015-09-30 | $7.17M | 4.38% |
| 2015-06-30 | $6.87M | 18.18% |
| 2015-03-31 | $5.81M | -10.52% |
| 2014-12-31 | $6.49M | -59.55% |
| 2014-09-30 | $16.05M | 223.30% |
| 2014-06-30 | $4.96M | 38.07% |
| 2014-03-31 | $3.60M | 191.88% |
| 2013-12-31 | $1.23M | 143.48% |
| 2013-09-30 | $506.00K | - |
Coherus BioSciences generated $64.98M in revenue during Q2 2024, up -15.68% compared to the previous quarter, and up 200.33% compared to the same period a year ago.
Coherus BioSciences Revenue Breakdown
Coherus BioSciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 19 |
|---|---|---|---|---|
| Other | $664.00K | $282.00K | - | - |
| Product Revenue | $256.58M | $210.76M | $326.60M | - |
| Product | - | - | - | $356.07M |
| License And Service | - | - | - | - |
Coherus BioSciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product Revenue (99.74%), and Other (0.26%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | $76.74M | $165.77M | $58.46M | $32.35M | $60.10M | $73.40M | - | - | - |
| Other | $320.00K | $322.00K | $259.00K | $83.00K | - | - | - | - | - |
| Product | - | - | - | - | - | - | $82.50M | $87.60M | $83.00M |
Coherus BioSciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product Revenue (99.58%), and Other (0.42%).
Coherus BioSciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 19 |
|---|---|
| UNITED STATES | $356.07M |
| Non Us | - |
Coherus BioSciences's latest annual revenue breakdown by geography, as of Dec 19: UNITED STATES (100.00%).
Coherus BioSciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CHRS | Coherus BioSciences | $257.24M | $64.98M |
| CTMX | CytomX Therapeutics | $101.21M | $25.11M |
| SPRO | Spero Therapeutics | $96.73M | $10.20M |
| BOLT | Bolt Biotherapeutics | $7.88M | $1.27M |
| ASMB | Assembly Biosciences | $7.16M | $5.79M |
| GRCL | Gracell Bio | - | - |
| NXTC | NextCure | - | - |
| TIL | Instil Bio | - | - |
| NLTX | Neurogene | - | - |
| ACHL | Achilles Therapeutics | - | - |
| NUVB | Nuvation Bio | - | $1.44M |
CHRS Revenue FAQ
What is Coherus BioSciences’s yearly revenue?
Coherus BioSciences's yearly revenue for 2023 was $257.24M, representing an increase of 21.89% compared to 2022. The company's yearly revenue for 2022 was $211.04M, representing a decrease of -35.37% compared to 2021. CHRS's yearly revenue for 2021 was $326.55M, representing a decrease of -31.37% compared to 2020.
What is Coherus BioSciences’s quarterly revenue?
Coherus BioSciences's quarterly revenue for Q2 2024 was $64.98M, a -15.68% decrease from the previous quarter (Q1 2024), and a 10.67% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $77.06M, a -15.80% decrease from the previous quarter (Q4 2023), and a 137.58% increase year-over-year (Q1 2023). CHRS's quarterly revenue for Q4 2023 was $91.52M, a 22.74% increase from the previous quarter (Q3 2023), and a 101.81% increase year-over-year (Q4 2022).
What is Coherus BioSciences’s revenue growth rate?
Coherus BioSciences's revenue growth rate for the last 3 years (2021-2023) was -21.22%, and for the last 5 years (2019-2023) was -27.75%.
What are Coherus BioSciences’s revenue streams?
Coherus BioSciences's revenue streams in c 23 are Other, and Product Revenue. Other generated $664K in revenue, accounting 0.26% of the company's total revenue, up 135.46% year-over-year. Product Revenue generated $256.58M in revenue, accounting 99.74% of the company's total revenue, up 21.74% year-over-year.
What is Coherus BioSciences’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Coherus BioSciences was Product Revenue. This segment made a revenue of $256.58M, representing 99.74% of the company's total revenue.